AWARENESS AMONG PEOPLE BASED ON NEURO ONCOLOGY
Mirkhamidova Sevara MirmakhmudovnaAssistant Of The Department Of The Public Health And Management, Tashkent Medical Academy, UzbekistanMuyassarova Mukhabbat MukhammadiyevnaSenior Teacher Of The Department Of Public Health And Management, Tashkent Medical Academy, UzbekistanAbdurashitova Sharafat AbdumajidovnaSenior Teacher Of The Department Of Public Health And Management, Tashkent Medical Academy, UzbekistanKarimbayev Shakhrambay DexkanbayevichTanisha RahimAssociate Professor (Phd) Of The Department Of Public Health And Management, Tashkent Medical Academy, Uzbekistan
ABI
Annotatsiya
Limitations in trial design, accrual, and data reporting impact efficient and reliable drug evaluation in cancer clinical trials. These concerns have been recognized in neuro-oncology but have not been comprehensively evaluated. We conducted a semi- automated survey of adult interventional neuro-oncology trials, examining design, interventions, outcomes, and data availability trends. Trials were selected programmatically from ClinicalTrials.gov using primary malignant CNS tumour classification terms. Regression analyses assessed design and accrual trends; effect size analysis utilized survival rates among trials investigating survival.
Hali tarjima qilinmagan
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos5 ta foydalanilgan manba